Hot Pursuit     04-Jul-24
Dr Reddys Laboratories Ltd spurts 1.14%, up for third straight session
Dr Reddys Laboratories Ltd is quoting at Rs 6498.95, up 1.14% on the day as on 12:49 IST on the NSE. The stock is up 25.5% in last one year as compared to a 25.55% gain in NIFTY and a 46.49% gain in the Nifty Pharma index.

Dr Reddys Laboratories Ltd rose for a third straight session today. The stock is quoting at Rs 6498.95, up 1.14% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.28% on the day, quoting at 24354.6. The Sensex is at 80227.97, up 0.3%. Dr Reddys Laboratories Ltd has added around 11.59% in last one month.

Meanwhile, Nifty Pharma index of which Dr Reddys Laboratories Ltd is a constituent, has added around 4.63% in last one month and is currently quoting at 19915.3, up 1.3% on the day. The volume in the stock stood at 1.64 lakh shares today, compared to the daily average of 6.23 lakh shares in last one month.

The benchmark July futures contract for the stock is quoting at Rs 6499.9, up 1.31% on the day. Dr Reddys Laboratories Ltd is up 25.5% in last one year as compared to a 25.55% gain in NIFTY and a 46.49% gain in the Nifty Pharma index.

The PE of the stock is 24.7 based on TTM earnings ending March 24.

Previous News
  Dr Reddys Lab jumps after Q4 PAT rises 22% YoY
 ( Hot Pursuit - 12-May-25   14:50 )
  Dr Reddys Laboratories
 ( Results - Analysis 10-May-25   15:37 )
  Dr Reddys Lab Q4 PAT rises 22% YoY
 ( Hot Pursuit - 10-May-25   10:52 )
  Dr Reddys Laboratories AGM scheduled
 ( Corporate News - 10-May-25   10:17 )
  Dr Reddys Laboratories fixes record date for final dividend
 ( Market Beat - Reports 09-May-25   19:13 )
  Dr Reddy's Laboratories consolidated net profit rises 21.64% in the March 2025 quarter
 ( Results - Announcements 09-May-25   17:18 )
  Board of Dr Reddys Laboratories recommends Final Dividend
 ( Corporate News - 09-May-25   17:01 )
  Dr Reddys announces cessation of subsidiary in Louisiana
 ( Corporate News - 24-Mar-25   13:48 )
  Dr Reddys Laboratories to conduct board meeting
 ( Corporate News - 22-Mar-25   11:01 )
  Dr. Reddy's recalls Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL in US
 ( Corporate News - 13-Mar-25   18:46 )
  Dr Reddys Laboratories allots 11,250 equity shares under ESOS
 ( Corporate News - 06-Mar-25   19:16 )
Other Stories
  Wendt (India) tanks as foreign promoter plans exit via OFS
  15-May-25   17:12
  Alembic Pharma rises on USFDA approval for Rivaroxaban Tablets
  15-May-25   16:36
  SSWL declines as Q4 PAT tumbles 88% YoY to Rs 61 cr
  15-May-25   15:44
  Saregama India gains after Q4 PAT climbs 12% YoY to Rs 60 cr
  15-May-25   15:29
  Apar Inds rises over 15% in two days on strong Q4 results
  15-May-25   15:27
  Cochin Shipyard spurts as Q4 PAT jumps 11% YoY to Rs 287 crore
  15-May-25   15:10
  Muthoot Finance Ltd leads losers in 'A' group
  15-May-25   15:00
  Persistent Systems tumbles as key US client faces criminal probe
  15-May-25   14:48
  Wendt India Ltd leads losers in 'B' group
  15-May-25   14:45
  ITC Hotels registers 20% YoY increase in Q4 PAT
  15-May-25   14:42
Back Top